Jan 18, 2024
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.33 to $0.02.
The split itself did not change the total investment value.
Panbela Therapeutics, Inc. (PBLA) trades on the Other OTC in the Biotechnology industry.
Panbela Therapeutics, Inc. company overviewThe latest split shown was on January 18, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 4 reverse splits between November 8, 2017 and January 18, 2024.